Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants

NCT07372703 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: VV913 1mg group
DRUG: VV913 2mg group
DRUG: VV913 4mg group
DRUG: VV913 8mg group
DRUG: VV913 15mg group
DRUG: VV913 25mg group
DRUG: VV913 40mg group

Sponsor

Vigonvita Life Sciences